Title:
Sustained release formulation composition for animals
Document Type and Number:
Japanese Patent JP6359234
Kind Code:
B2
Abstract:
The present invention relates to a sustained-release pharmaceutical composition intended for animal use, which comprises a drug, a sugar, a wax, and a water-soluble polymer.
More Like This:
WO/2009/052231 | CRYSTALLINE CHEMOTHERAPEUTIC |
JP2010248205 | BENZAZOLE DERIVATIVE FOR TREATING SCLERODERMA |
JP4673294 | Bicyclic anilide spirohydantoin CGRP receptor antagonist |
Inventors:
Kuriyama Teruaki
Application Number:
JP2018519883A
Publication Date:
July 18, 2018
Filing Date:
June 08, 2017
Export Citation:
Assignee:
ds Pharma Animal Health Co., Ltd.
International Classes:
A61K31/423; A61K9/22; A61K47/12; A61K47/14; A61K47/26; A61K47/36; A61K47/38; A61K47/44; A61P25/08
Domestic Patent References:
JP6210012A | ||||
JP2009517394A | ||||
JP2000119181A | ||||
JP2011173881A | ||||
JP2011528702A | ||||
JP2011519878A |
Foreign References:
CN102949365A |
Other References:
DSファーマアニマルヘルス,コンセーブ(登録商標)錠(製品概要)[オンライン],2014年10月,[検索日2017.06.23], インターネット:,
PODELL M. et al.,2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs,Journal of Veterinary Internal Medicine,2016年 2月22日,Vol.30,Issue2,p.477-490,[online],[retrieved on 2017.06.26],Retrieved from the Internet
PODELL M. et al.,2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs,Journal of Veterinary Internal Medicine,2016年 2月22日,Vol.30,Issue2,p.477-490,[online],[retrieved on 2017.06.26],Retrieved from the Internet
Attorney, Agent or Firm:
Takuji Yamada
Nagatoshi Shinagawa
Kure Hidenori
Mizuhara Masahiro
Nagatoshi Shinagawa
Kure Hidenori
Mizuhara Masahiro
Previous Patent: A vehicle guiding device and a vehicle guidance method
Next Patent: SERIAL SIGNAL TRANSMISSION EQUIPMENT
Next Patent: SERIAL SIGNAL TRANSMISSION EQUIPMENT